Home > In process > Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma. > Access to Fulltext
 
 
Main document file(s):
Similar records

DZNEPUB :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2601a
Maintained by j2-admin@dzne.de

Impressum | Data Privacy Policy